On June 22, the United States Food and Drug Administration (FDA) announced the recall of more than 11,000 bottles of blood pressure medication due to a manufacturing defect. Namely, the tablets were found to have "failed dissolution specifications."
The recall was voluntarily initiated on June 5 by Inventia Healthcare Limited of India, the company that manufactured the drug, and is still ongoing. The medication was distributed in the US by Rising Pharma Holdings of East Brunswick, New Jersey.
A total of 11,460 bottles of medication affected by the recall contain 25 mg USP chlorthalidone tablets with an expiration date of April 2027.
In recent years, the number of recalls in America has been increasing. But what is a recall, exactly?
Essentially, a product recall occurs when manufacturers identify defects or safety concerns that could pose risks to consumers. Intrigued? Click through and discover the goods that fell victim to a total recall.